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Abstract: Climate change has become a controversial topic in today’s media despite decades of
warnings from climate scientists and has influenced human health significantly with the increasing
prevalence of infectious pathogens and contribution to antimicrobial resistance. Elevated temperatures
lead to rising sea and carbon dioxide levels, changing environments and interactions between humans
and other species. These changes have led to the emergence and reemergence of infectious pathogens
that have already developed significant antimicrobial resistance. Although these new infectious
pathogens are alarming, we can still reduce the burden of infectious diseases in the era of climate
change if we focus on One Health strategies. This approach aims at the simultaneous protection
of humans, animals and environment from climate change and antimicrobial impacts. Once these
relationships are better understood, these models can be created, but the support of our legislative
and health system partnerships are critical to helping with strengthening education and awareness.
Keywords: climate change; One Health; Candida auris; COVID 19; emerging pathogens;
antimicrobial resistance

Climate change has become a controversial topic in today’s media despite decades of warnings
from climate scientists [1,2]. Reports of “The Hottest Month Ever Recorded,” “Glaciers Melting” and
“Earth’s Food Supply Under Threat” are news headlines with which people have become familiar [3].
Most recently, the Australian wildfires are another example of the urgency to address climate change.
Additionally, several studies suggest climate change is contributing to infectious disease emergence [4].
The Centers for Disease Control and Prevention stated that the impact of climate change on human
health is significant [5]. Increasing temperatures have led to extreme weather resulting in rising sea and
carbon dioxide levels, which contributes to increased prevalence of infectious agents. These changes
affect adaptations in vector ecology, water quality and decreased nutritional supply that are associated
with infectious diseases such as tickborne encephalitis, cryptosporidiosis and leptospirosis [2,6]. It also
contributes to increased antimicrobial resistance [7]. We analyze the One Health approach, which
focuses on the simultaneous protection of humans, animals and the environment from climate change
and antimicrobial impact [8].
The relationship between global warming and infectious pathogens dates back many years.
For example, Roman aristocrats used to vacation in the summer at hill resorts to avoid malaria [9].
Although humans thought they could “outsmart” these infections, many viruses, bacteria, protozoa
and multicellular parasites have evolved to the human species as their natural reservoir through
vector-borne transmission [10]. These infectious agents adapt to their optimal climate that includes
temperature, precipitation, elevation and daylight duration. According to the Centers for Disease
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Control and Prevention, about 75% of emerging diseases and 60% of known human infectious diseases
originate in animals. It is imperative that we learn to diagnose and control zoonotic infections,
while evaluating the impact of human activity and environmental change on nonhuman reservoirs of
disease [11].
Even though climate change impact and its effect on infectious diseases are well reported, it is
occurring at an accelerated rate. Legionnaires’ disease, a waterborne illness, is rising with a rate
of reported cases increasing 5.5 times from 2000 to 2017 [12]. Vector-borne infections such as Zika,
Chagas disease, dengue and chikungunya that are usually localized to tropical climates as they require
higher temperatures to complete their life cycle, are slowly migrating towards temperate climates,
such as the United States, as global temperatures are increasing even in winter months [13]. Malaria is
the most prevalent vector-borne disease globally [14,15]. Temperature and humidity are among the
most important factors for disease transmission and extrinsic incubation period, and are facilitating
the spread of malaria into areas that are currently malaria-free large urban highland populations [9].
Similarly, dengue viruses are traditionally transmitted in the tropics because frost and sustained cold
weather kills adult mosquitoes and overwintering eggs and larvae [16,17]. Warming trends are shifting
the vector and disease distribution to higher latitudes and altitudes. Warmer temperatures reduce the
larval size of the Aeagypti mosquito as well, requiring the adult to feed more frequently, increasing bite
rates and spread of infection [18,19]. Additionally, mosquito-borne diseases, such as West Nile virus,
that typically occur during the rainy season are now occurring during the drought season. This shift is
occurring because mosquitoes are brought into proximity with birds at scarce water sources, enhancing
the transmission of the virus in the enzootic cycle [13,20,21].
Tickborne infections that were once thought to be confined to the Northeast United States are now
expanding throughout the Midwest and further West. This is in part due to increased temperatures,
which are increasing the survival and activity period of ticks, allowing extension of the range of both
the reservoir and tick hosts. Additionally, this prolongs the duration of the season when people
are exposed to the ticks [22]. Bacterial and protozoan tickborne diseases doubled in the United
States between 2004 and 2016 as reports of both Ixodes scapularis and Amblyomma americanum ticks are
expanding to new areas [23,24]. These ticks are known to transmit infections such as Lyme disease,
Anaplasma phagocytophilum, babesiosis, human monotrophic ehrlichiosis and tularemia.
Diarrheal diseases such as Campylobacter, Salmonella and cholera survive better in warmer
temperatures and, with the increasing temperatures in our water systems, we have seen the reemergence
of these diarrheal infections in recent years [20,25]. This is particularly alarming as we already have
significant antimicrobial resistance to these Gram-negative pathogens, and as these bacteria evolve,
treatment options may be limited [20,26–28]. For example, there have already been numerous outbreaks
of Salmonella typhi with resistance to several key therapeutic antimicrobials such as ciprofloxacin;
however, now nontyphoidal salmonellas, which are being frequently transmitted by means of
contaminated water supply, have developed decreased susceptibility to fluoroquinolone antimicrobials
in developing countries [29]. Additionally, Gonzalez et al. found that Campylobacter jejuni survives in
well water for long periods of time and the effect of ciprofloxacin resistance was temperature-dependent
as the resistance mechanisms in vitro increased as temperatures went from 4 to 25 ◦ C [30].
A well-known infection that is hypothesized to have arisen from climate change is Candida auris,
which previously existed as a plant saprophyte and gained thermotolerance and salinity tolerance
from the effects of climate change on the wetland ecosystem [31,32]. C. auris was first isolated in 2009
from a human ear and since then has been associated with human disease in many countries and
exhibited nonsusceptibility to antifungal agents [32]. This new thermotolerant C. auris was proposed
to have been transplanted by birds across the globe to rural areas where humans and birds are in
constant contact. Human migration likely led to the emergence of C. auris into urban healthcare
environments in which antimicrobial resistance and infection control issues have arisen. C. auris is
the only Candida species that has isolates shown to be resistant to all four classes of antifungal drugs,
which has created higher risks for clinical infections and breakthrough infections during antifungal
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treatment and prophylaxis [33]. These infections have the potential to result in significant morbidity
and mortality and could be on the rise as climate change continues [3].
SARS-COV-2, the virus responsible for COVID-19, originated from the interplay between humans
and animals. The likely transmission of the virus came from bats and potentially used an intermediate
source, the pangolin, to transmit the virus to humans [34]. Many of the initial cases had a common
exposure to the Huanan wholesale seafood market that also traded live animals. On 7 January 2020,
the virus was sequenced and was found to have >95% homology with the bat coronavirus [35]. Through
travel and community spread, it has become a global pandemic. Bats are especially vulnerable to
climate change due to low reproductive output, ecological specialization and high trophic positions [36].
Their large surface area of noninsulated wings create significant water loss that is higher than in
other small animals [37]. Thus, with climate change, increased aridity and prolonged droughts in
their endemic areas bats migrate to more populated areas in search of insect prey, thereby increasing
their interaction with humans, and as a result, may transmit virulent infections [37,38]. Additionally,
although the prevalence of confirmed community-onset bacterial coinfections are low in patients
with COVID-19, 56.6% of hospitalized patients in 38 Michigan hospitals received empiric antibiotic
therapy [38]. This study and many others bring to light the urgency of antimicrobial stewardship
principles to prevent antimicrobial resistance during the COVID-19 era [39].
The implications of antimicrobial resistance due to the emergence and reemergence of infectious
pathogens from climate change are complex as the decreasing effectiveness of antibiotics has accelerated
in recent years [40]. In 2016, a U.K government-commissioned report estimated that if no action
were taken, by 2050, antimicrobial resistance would cause up to 10 million annual deaths globally,
reduce gross domestic product by 2% to 3.5% and cost 100 trillion US dollars [41]. A key feature of
antimicrobial resistance and climate change is that antibiotic consumption and carbon use will bring
about adverse future consequences [42]. Tackling this issue has led to the establishment of a global
innovation fund for both antimicrobial resistance research and investing in new drugs; however, both
developments are financially competing against each other [43].
Recent evidence shows that higher temperatures are associated with higher resistance levels in
common pathogens such as Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus [44]. In an
unadjusted analysis, MacFadden et al. demonstrated an increase of 10◦ C across all regions in the
United States was associated with increased resistance of 5.1%, 3.4% and 3.1% for E. coli, K. pneumoniae
and S. aureus respectively [45]. This association postulates that due to horizontal gene transfer, warmer
temperatures could affect the way bacteria respond to certain drug mechanisms [45]. Another recent
study suggested an association between temporal climate developments and carbapenem-resistance in
Pseudomonas aeruginosa in Europe [7]. Climate change and antimicrobial resistance are also driven by
the consumption of carbon and antibiotics that can provide people with valuable short term benefits
but impose long term costs [44,46]. Although both antimicrobial resistance and climate change are
not wholly comparable, both issues require participation from the local, national and international
organizations to help solve their challenges [47].
Additionally, animal and environmental compartments play a significant role in antimicrobial
resistance [48]. There are multiple links between humans, animals and environmental compartments
allowing for movement and alteration of genetic elements of bacteria and creating resistance to
antimicrobials [45,49]. Industrial agriculture relies heavily on the widespread use of antimicrobials for
livestock farms for therapeutics, prophylactics and controversially growth promotion [48]. Agricultural
usage of antimicrobials exceeds and rivals medical usage in the United States and Europe respectively,
and observational studies and surveillance reports have described antimicrobial resistance in farm
animals resulting from misuse [40,48]. Small doses of antibiotics from urine, feces, manure and
pharmaceutical waste are also being released into the environment through rivers, lakes and
soil [50]. These sublethal doses allow for antimicrobial resistance to occur as they do not reach
“cidal” concentrations [51].
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With the emergence and the reemergence of these infectious pathogens, our hospital systems
need to be equipped with the proper resources and education. Infection control and antimicrobial
stewardship efforts will need to adapt and be prepared for these pathogens as they become more
resistant to antimicrobials and cause “outbreaks” in hospital settings. Sentinel, vector, syndromic and
real-time surveillance will be necessary to monitor changes related to climate change to help hospitals
prepare for the emergence of new pathogens [25]. Evidence-based epidemic intelligence with early
identification of infectious disease threats related to climate change is crucial to help with adaptation
and preparedness for these outbreaks [25]. Microbiology laboratories will need to develop advanced
capacity to identify these new organisms. As more infections are transmitted from animal reservoirs,
communication between veterinarians and clinicians will be necessary in order to prevent animal
transmission to humans that could lead to significant morbidity and mortality [8].
Although these new infectious pathogens and potential for increased antimicrobial resistance are
alarming, we can still reduce the burden of infectious disease in the era of climate change if we focus
on One Health strategies. We must acknowledge both the fragility of our healthcare systems and the
healthcare’s own large carbon footprint [52]. One Health is an approach that recognizes that the health
of people is closely connected to the health of animals and our shared environment. This is not a new
concept, but one that is becoming important in recent years as human populations are growing and
expanding into new geographic areas [8,53]. More people are now living in close contact with wild and
domestic animals, both livestock and pets. Close contact with animals and their environments provides
more opportunities for diseases to pass between animals and people. Additionally, our planet has
experienced changes such as deforestation and intensive farming practices because of climate change.
Disruptions in environmental conditions and habitats can provide new opportunities for diseases to
pass to animals. Finally, the movement of people, animals and animal products has increased from
international travel and trade leading to global transmission of pathogens as we are now seeing with
COVID-19 [53–55].
The One Health concept is gaining recognition in the United States and globally as an effective way
to fight health issues at the human–animal–environment interface. Preventative One Health strategies,
such as mass vaccinations of animal populations can help reduce livestock-mediated zoonoses, and
is both feasible and cost-effective [56]. Livestock vaccination against brucellosis and leptospirosis
has been effective in reducing the burden of disease in many parts of the world where diagnosis and
treatment of these diseases are limited [56–58]. International implementation by the World Health
Organization has already utilized the One Health approach for Influenza A H1N1 in 2009, Polio in
2014, Ebola in 2014 and the Zika virus in 2016 by declaring them potential public health emergencies
of international concern. This approach has had relative success by incorporating aspects of human,
animal and environmental health to help with mitigation of these diseases [59]. However, there is
controversy if One Health will be enough to fight climate change [8]. To implement this protection,
we need to learn more about the underlying complex relationships of these pathogens and vectors
and develop well-designed mitigation measures. Successful public health interventions require the
cooperation of human, animal, and environmental health partners. Professionals within these sectors
need to communicate, collaborate and coordinate activities [53,54]. Once these relationships are
better understood, these models can be created, but the support of our legislative and health system
partnerships are critical to helping with strengthening education and awareness.
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